Shoshanna Fischhoff

A new NIDDK grant will allow researchers to study the role of senescent cells in diabetic neuropathy, opening the door to new diagnostics and treatments.

The Research Scientist recently joined the NeuroNetwork for Emerging Therapies.

A review in Nature Reviews Neurology looks at this increasingly problematic global issue.

Our study, published in Diabetes Research and Clinical Practice, examined whether diabetes and related complications increase dementia risk independent of other risk factors.

Current Protocols published a new protocol we developed to better test stem cell therapeutics.

A new grant from the National Institute of Neurological Disorders and Stroke aims to improve the diagnosis of ALS, better predict disease progression, and identify new treatment options.

NBC News interviewed Dr. Stephen Goutman about the link between pesticides and ALS.

Dr. Feldman joins the Biointerfaces Institute

A new review discusses the mechanisms connecting the two conditions and coins a new term to describe it – "stocking-glove-hat.”

Reader's Digest's The Healthy interviewed Dr. Eva L. Feldman about what to do in the morning to keep your brain sharp.

Dr. Eva Feldman was interviewed by The Washington Post about the current state of ALS research.

Daily Mail interviewed Dr. Eva Feldman about the possible cause for certain ALS hotspots.

Dr. Feldman re-elected to the National Academy of Medicine Council. The Council is the Academy’s governing and oversight body.

The University of Michigan School of Dance staged a beautiful multidisciplinary concert to benefit research on neurodegenerative disease.

Dr. Kevin Chen was installed as the inaugural recipient, thanks to the generosity of Regent Emerita Andrea Fischer Newman and Frank Newman.